BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30484395)

  • 1. GHB Pharmacology and Toxicology: From Metabolism and Pharmacokinetics to Applications: In Clinical and Forensic Toxicology.
    Busardò FP; Vergallo GM; Plazzi G
    Curr Drug Metab; 2018; 19(13):1054-1055. PubMed ID: 30484395
    [No Abstract]   [Full Text] [Related]  

  • 2. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.
    Felmlee MA; Morse BL; Morris ME
    AAPS J; 2021 Jan; 23(1):22. PubMed ID: 33417072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
    Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
    Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
    Borgen LA; Okerholm RA; Lai A; Scharf MB
    J Clin Pharmacol; 2004 Mar; 44(3):253-7. PubMed ID: 14973300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
    Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
    Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs.
    Ricci G; Busardò FP; Gibelli F; Sirignano A; Brunetti P
    Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1445-1454. PubMed ID: 35043730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHB urine concentrations after single-dose administration in humans.
    Odujebe O; Landman A; Hoffman RS
    J Anal Toxicol; 2007 Apr; 31(3):179; author reply 179-80. PubMed ID: 17579967
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats.
    Pedraza C; García FB; Navarro JF
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1165-77. PubMed ID: 19288974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.
    Ferrara SD; Zotti S; Tedeschi L; Frison G; Castagna F; Gallimberti L; Gessa GL; Palatini P
    Br J Clin Pharmacol; 1992 Sep; 34(3):231-5. PubMed ID: 1389947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three deaths associated with use of Xyrem.
    Zvosec DL; Smith SW; Hall BJ
    Sleep Med; 2009 Apr; 10(4):490-3. PubMed ID: 19269893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
    Engelsen J; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Narcolepsy with Sodium Oxybate While Breastfeeding: A Case Report.
    Gashlin LZ; Sullo D; Lawrence RA; Rosen-Carole C
    Breastfeed Med; 2016 Jun; 11(5):261-3. PubMed ID: 27057786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.
    Corkery JM; Loi B; Claridge H; Goodair C; Schifano F
    Curr Drug Metab; 2018; 19(13):1086-1099. PubMed ID: 29119924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-drug intoxication fatality involving Xyrem (GHB).
    Akins BE; Miranda E; Lacy JM; Logan BK
    J Forensic Sci; 2009 Mar; 54(2):495-6. PubMed ID: 19187456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.